Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Saved in:
| Title: | Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. |
|---|---|
| Authors: | Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam a.p.kater@amc.uva.nl., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam., van Norden Y; Department of Hematology - HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam., van der Straten L; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht., Driessen J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam., Posthuma WFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft.; Department of Hematology, Leiden University Medical Center., Schipperus M; Department of Hematology, Haga Hospital, the Hague., Chamuleau MED; Department of Hematology, VU University Medical Center, Amsterdam., Nijland M; Department of Hematology, University Medical Center, Groningen., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam., Van Gelder M; Department of Hematology, Maastricht University Medical Center., Hoogendoorn M; Department of Internal Medicine, Medical Center, Leeuwarden., De Croon F; Department of Internal Medicine, Ikazia Hospital, Rotterdam., Wittebol S; Department of Internal Medicine, Gelderland Valley Hospital, Ede., Kerst JM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam., Marijt EWA; Department of Hematology, Leiden University Medical Center., Raymakers RAP; Department of Hematology, University Medical Center, Utrecht., Schaafsma MR; Department of Hematology, Medical Spectrum Twente, Enschede., Dobber JA; Laboratory Special Hematology, Academic Medical Center, Amsterdam, the Netherlands., Kersting S; Department of Hematology, Haga Hospital, the Hague., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht. |
| Corporate Authors: | HOVON CLL study group |
| Source: | Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. 147-154. Date of Electronic Publication: 2018 Aug 16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30115656 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kater+AP%22">Kater AP</searchLink>; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam a.p.kater@amc.uva.nl.<br /><searchLink fieldCode="AU" term="%22van+Oers+MHJ%22">van Oers MHJ</searchLink>; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam.<br /><searchLink fieldCode="AU" term="%22van+Norden+Y%22">van Norden Y</searchLink>; Department of Hematology - HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam.<br /><searchLink fieldCode="AU" term="%22van+der+Straten+L%22">van der Straten L</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht.<br /><searchLink fieldCode="AU" term="%22Driessen+J%22">Driessen J</searchLink>; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam.<br /><searchLink fieldCode="AU" term="%22Posthuma+WFM%22">Posthuma WFM</searchLink>; Department of Internal Medicine, Reinier de Graaf Hospital, Delft.; Department of Hematology, Leiden University Medical Center.<br /><searchLink fieldCode="AU" term="%22Schipperus+M%22">Schipperus M</searchLink>; Department of Hematology, Haga Hospital, the Hague.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Department of Hematology, VU University Medical Center, Amsterdam.<br /><searchLink fieldCode="AU" term="%22Nijland+M%22">Nijland M</searchLink>; Department of Hematology, University Medical Center, Groningen.<br /><searchLink fieldCode="AU" term="%22Doorduijn+JK%22">Doorduijn JK</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam.<br /><searchLink fieldCode="AU" term="%22Van+Gelder+M%22">Van Gelder M</searchLink>; Department of Hematology, Maastricht University Medical Center.<br /><searchLink fieldCode="AU" term="%22Hoogendoorn+M%22">Hoogendoorn M</searchLink>; Department of Internal Medicine, Medical Center, Leeuwarden.<br /><searchLink fieldCode="AU" term="%22De+Croon+F%22">De Croon F</searchLink>; Department of Internal Medicine, Ikazia Hospital, Rotterdam.<br /><searchLink fieldCode="AU" term="%22Wittebol+S%22">Wittebol S</searchLink>; Department of Internal Medicine, Gelderland Valley Hospital, Ede.<br /><searchLink fieldCode="AU" term="%22Kerst+JM%22">Kerst JM</searchLink>; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam.<br /><searchLink fieldCode="AU" term="%22Marijt+EWA%22">Marijt EWA</searchLink>; Department of Hematology, Leiden University Medical Center.<br /><searchLink fieldCode="AU" term="%22Raymakers+RAP%22">Raymakers RAP</searchLink>; Department of Hematology, University Medical Center, Utrecht.<br /><searchLink fieldCode="AU" term="%22Schaafsma+MR%22">Schaafsma MR</searchLink>; Department of Hematology, Medical Spectrum Twente, Enschede.<br /><searchLink fieldCode="AU" term="%22Dobber+JA%22">Dobber JA</searchLink>; Laboratory Special Hematology, Academic Medical Center, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersting+S%22">Kersting S</searchLink>; Department of Hematology, Haga Hospital, the Hague.<br /><searchLink fieldCode="AU" term="%22Levin+MD%22">Levin MD</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22HOVON+CLL+study+group%22">HOVON CLL study group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2019 Jan; Vol. 104 (1), pp. 147-154. <i>Date of Electronic Publication: </i>2018 Aug 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30115656 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3324/haematol.2018.193854 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 147 Titles: – TitleFull: Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kater AP – PersonEntity: Name: NameFull: van Oers MHJ – PersonEntity: Name: NameFull: van Norden Y – PersonEntity: Name: NameFull: van der Straten L – PersonEntity: Name: NameFull: Driessen J – PersonEntity: Name: NameFull: Posthuma WFM – PersonEntity: Name: NameFull: Schipperus M – PersonEntity: Name: NameFull: Chamuleau MED – PersonEntity: Name: NameFull: Nijland M – PersonEntity: Name: NameFull: Doorduijn JK – PersonEntity: Name: NameFull: Van Gelder M – PersonEntity: Name: NameFull: Hoogendoorn M – PersonEntity: Name: NameFull: De Croon F – PersonEntity: Name: NameFull: Wittebol S – PersonEntity: Name: NameFull: Kerst JM – PersonEntity: Name: NameFull: Marijt EWA – PersonEntity: Name: NameFull: Raymakers RAP – PersonEntity: Name: NameFull: Schaafsma MR – PersonEntity: Name: NameFull: Dobber JA – PersonEntity: Name: NameFull: Kersting S – PersonEntity: Name: NameFull: Levin MD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2019 Jan Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1592-8721 Numbering: – Type: volume Value: 104 – Type: issue Value: 1 Titles: – TitleFull: Haematologica Type: main |
| ResultId | 1 |
